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A 79-year-old man who had undergone a right femoropopliteal (FP) bypass operation 6 weeks previ-
ously was diagnosed with vascular graft infection caused by Staphylococcus lugdunensis.  Another FP 
bypass operation was performed,  with long-term administration of antibiotics,  and the patient eventu-
ally recovered well without any recurrences for over 2 years.  Although S. lugdunens is classiﬁed as 
coagulase-negative Staphylococcus,  its pathogenicity has been reported to be equal to that of S. 
aureus.  Based on the literature review,  the organism characteristically colonizes the inguinal area of 
human skin; thus,  operations such as FP bypass grafting may place patients at a relatively high risk 
for infection by S. lugdunensis,  a potentially high-pathogenicity organism.
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enerally,  coagulase-negative Staphylococcus (CNS) 
is considered relatively less pathogenic than 
Staphylococcus aureus.  In fact,  CNS rarely causes 
severe diseases in clinical situations.  However,  
Staphylococcus lugdunensis,  though microbiologically 
classiﬁed into CNS,  has high pathogenicity,  compa-
rable to that of S. aureus,  with a poor prognosis [1].  
To date,  various kinds of S. lugdunensis infection cases 
such as infective endocarditis (IE),  skin and soft tis-
sue infection,  and bone and joint infection have been 
reported.  As with other CNS organisms,  it often 
manifests in conjunction with prosthetic devices;  
infections related to artiﬁcial joints,  ventriculo-peri-
toneal shunts,  heart valves,  and pacemakers have been 
also described [2].  Recently,  Choi et al.  reported 
that approximately 60ｵ of nosocomial S. lugdunensis 
bacteremia cases were caused by central line infection 
[3].  However,  there has been no well-documented 
report concerning vascular graft infection (VGI) so 
far.  Here,  we report a case of S. lugdunensis VGI after 
a femoropopliteal (FP) bypass grafting operation.
Case Report
　 A 79-year-old man (Height: 167cm,  Body weight:  
60kg) with a history of hypertension (for 9 years),  
arteriosclerosis obliterans (ASO),  and vascular graft 
bypass of the left lower extremity (9 years previ-
ously),  presented at our hospital with 2 daysʼ history 
of right leg lassitude and coldness.  The ankle brachial 
index (ABI) was 0.29 on right side and 0.99 on left 
side.  He was diagnosed with ASO of the right femoral 
artery (Fontaine class 2) and received a right FP 
bypass operation using a Gore-Tex graft.  In the nor-
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mal clinical course after surgery,  clinical symptoms 
and ABI showed improvement,  and he was discharged 
without any complications.
　 Approximately 6 weeks later,  the patient returned 
to the hospital complaining of mild fever and right 
femoral pain.  Upon examination,  a surgeon observed 
exudate leaking from the surgical wound,  although the 
concurrent laboratory examination had not detected 
elevation of inﬂammatory markers.  Irrigation and oral 
antibiotic (cefcapene pivoxil) was initiated; however,  
high fever emerged and the patient was readmitted 60 
days after the initial operation.
　 His vital signs on readmission were as follows:  
blood pressure,  130/68mmHg; heart rate,  96 beats 
per minute; body temperature,  39.0℃.  Physical 
examination revealed redness and tenderness of the 
inner aspect of his right thigh.  The patient did not 
exhibit any symptoms relating to IE such as cardiac 
murmur or embolization of peripheral vessels.  His 
transthoracic echocardiogram was negative for vegeta-
tion on valves.  Laboratory testing revealed an ele-
vated inﬂammatory status (white blood cell count,  
9,900/mm3; and C-reactive protein level,  10.2mg/
dL),  but no other speciﬁc results.  The infected graft 
was completely removed,  and another right FP bypass 
operation was performed,  again with synthetic Gore-
Tex graft.  This time the bypass was routed via the 
lateral side of the infected femoral region to avoid 
re-infection.  The surgical wound was left open and 
vacuum-assisted closure (VAC) therapy was initiated.  
Gram staining of the abscess pooled around the 
infected graft revealed inﬂammatory cells and Gram-
positive cluster-forming cocci,  and linezolid (600mg 
every 12h) was initiated intravenously.
　 Later,  S. lugdunensis was detected from two sets of 
blood cultures,  the abscess obtained from the surgical 
site,  and a thrombus inside the graft (Microscan 
Walkaway,  SIEMENS,  CA,  USA).  According to the 
result of antibiotics susceptibility testing (Table 1),  
the antibiotic was changed to vancomycin 2 weeks 
after the operation,  and a total of 8 weeks of intrave-
nous antibiotic therapy was successfully given.  VAC 
therapy was regularly performed every 3 to 4 days 
and continued for approximately 8 weeks.  Complete 
healing of the local wound was ﬁnally achieved and the 
patient was discharged without any subsequent infec-
tious complications over 2 years.
Discussion
　 S. lugdunensis was ﬁrst detected in 1988 and dif-
ferentiated from the closely related but more virulent 
S. aureus by its inability to produce free coagulase 
[4].  Among over 40 recognized species of CNS,  this 
organism is unique in 2 major points.
　 First is its similarity to S. aureus with respect to 
pathogenicity and biochemical properties: S. lugdunen-
sis has the potential to cause infections as severe as 
those attributable to S. aureus.  In fact,  a recent 
guideline suggests that S. lugdunensis bacteremia should 
be managed the same way as S. aureus bacteremia [5].  
In contrast to other CNS organisms,  S. lugdunensis is 
known to possess the same virulence factors as S. 
aureus,  such as delta toxin-like hemolytic peptide,  
vitronectin (DNase and lipase),  esterases,  lysosome 
resistance,  bioﬁlm formation,  and others [1].  The 
biochemical properties of S. lugdunensis also resemble 
those of S. aureus.  The organism can be easily mis-
taken for S. aureus if identiﬁcation is based only on the 
latex agglutination test.  S. lugdunensis can be diﬀeren-
tiated from S. aureus by ornithine decarboxylase detec-
tion,  generation of acid from D-mannitol,  and the 
pyrrolidonyl aminopeptidase test (Table 2).
　 The second distinctive characteristic of S. lugdun-
ensis is its antibiotic susceptibility.  According to the 
Clinical and Laboratory Standards Institute,  its 
resistance to oxacillin is the same as that of S. aureus.  
172 Acta Med.  Okayama　Vol.  68,  No.  3Hagiya et al.
Table 1　 Antibiotic susceptibility testing of S. lugdunensis
Antibiotics MIC (µg/mL)
Penicillin G ＞8
Ampicillin ＞8
Cefazolin ≦8
Cefotiam ≦8
Flomoxef ≦4
Imipenem ≦1
Gentamicin ＞8
Arbekacin 2
Minocycline ≦2
Clindamycin ≦0.5
Levoﬂoxacin ≦0.5
Fosfomycin ＞16
Sulfamethoxazole/Trimethoprim ≦1
Vancomycin 2
Teicoplanin ≦2
Linezolid ≦2
MIC,  minimum inhibitory concentration.
While other CNS organisms are generally resistant to 
oxacillin,  S. lugdunensis is generally susceptible to 
most anti-staphylococcal antibiotics,  including penicil-
lin.  Beta-lactamase production is found in only 
approximately 25ｵ of strains,  and methicillin resis-
tance is uncommon [6].  The pathogen in the present 
case was a methicillin-sensitive strain.
　 To date,  a variety of S. lugdunensis infections have 
been reported.  Frank et al.  summarized clinical cases 
caused by S. lugdunensis in their review article in 
2008 [7],  and concluded that IE,  mainly involving 
native valves,  is a major clinical manifestation.  
According to Liu et al.,  who conducted a retrospec-
tive literature review and summarizend 67 cases of S. 
lugdunensis IE between 1988 and 2008 [8],  more than 
80ｵ occurred as left-sided valvular IE,  66.7ｵ 
required valve replacement operations,  and the mor-
tality was 38.8ｵ.  We further investigated recent S. 
lugdunensis infection cases by performing an English-
language search of PubMed from 2008 to September 
2013,  using the keyword phrase “Staphylococcus lug-
dunensis”.  On the basis of 243 cases from 49 articles,  
it was revealed that skin and soft tissue infection,  
followed by IE,  is the most common manifestation of 
S. lugdunensis,  as shown in Fig.  1 [1,  9-14].
　 As with other CNS organisms,  S. lugdunensis is a 
normal ﬂora of the human skin and has high potential 
to become involved with indwelling medical devices 
[2].  Importantly,  S. lugdunensis characteristically 
resides at the perineum and inguinal area [15-19].  
Vascular grafts originating in the groin area as in the 
present case generally have the highest rates of infec-
tion among the various types of vascular grafts.  
Therefore,  we assume that FP bypass places patients 
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Fig. 1　 A summary of previously reported cases of Staphylococcus lugdunensis infection.  The summary is composed of 243 cases 
derived from 49 publications including case reports,  case series,  and reviews concerning Staphylococcus lugdunensis infection that were 
reported from 2008 through September 2013.  The designation “skin and soft tissue infection” includes cellulitis,  necrotizing fasciitis,  
subcutaneous abscess,  and iliopsoas abscess.  CNS,  central nervous system; OG,  obstetrics and gynecology; and CAPD,  continuous 
ambulatory peritoneal dialysis.
Table 2　 Biochemical characteristics of S. aureus and S. lug-
dunensis
S. aureus S. lugdunensis
Oxidase (－) (－)
Ornithine decarboxylase (－) (＋)
Sucrose (＋) (＋)
Maltose (＋) (＋)
D-mannitol (＋) (－)
D-mannose (＋) (＋)
D-trehalose (＋) (＋)
D-ribose (＋) (－)
Agglutination test (＋) (－)
Clumping test (＋) (＋)
Thermostable nucleases (＋) (－)
pyrrolidonyl aminopeptidase test (－) (＋)
at a relatively high risk for S. lugdunensis infection.  
Although S. lugdunensis infections of indwelling medical 
devices have been reported [2],  a literature review 
found no previous case involving VGI.  The infections 
caused by this organism are known to have the poten-
tial to cause severe infection as discussed above.  
Thus,  we consider that VGI caused by S. lugdunensis 
should be separated from other etiologies.
　 In general,  antimicrobial therapy alone without 
surgery is associated with a high mortality [20].  
Graft excision and revascularization through a non-
infected site are essential for treatment of VGI.  
Revascularization can be accomplished by extra-ana-
tomic bypass or partial graft excision and in situ 
reconstruction with arterial allografts,  autologous 
veins,  or antibiotic- or silver-bonded prosthetic grafts 
[21].  Among these,  the incidence of infection in arte-
rial allografts or autologous veins is lower than in 
prosthetic vascular grafts [22].  The eﬃcacy of 
rifampicin-bonded grafts in preventing graft infection 
has been reported by 3 randomized controlled trials 
[23-25].  In our case,  revascularization was per-
formed using a non-antibiotic-bonded prosthetic vascu-
lar graft.  However,  considering the risk of reinfec-
tion,  the previously proven method could be an option.
　 Since the patientʼs skin,  particularly at the inguinal 
area,  is a major source of S. lugdunensis,  improving 
preoperative skin management is important for pre-
vention.  Preoperative bathing with a detergent alone 
can be of use [26].  The eﬀect of daily bathing with 
chlorhexidine on the acquisition of methicillin-resis-
tant Staphylococcus aureus has been reported in ICU 
patients [27,  28],  and such a method can be applied 
for the prevention of S. lugdunensis infection.  In addi-
tion,  2ｵ chlorhexidine-based preparations are reported 
to be superior to 10ｵ povidone-iodine in preventing 
surgical site infection [29],  although 0.5 to 1ｵ chlo-
rhexidine solution is commonly used in Japan.  Skin 
preparation using such an appropriate antiseptic agent 
is evaluated as critical to prevention in guidelines 
[30-32].  In the inguinal area,  hair removal can be of 
concern.  Removing hair using a razor is no longer 
recommended [32]; if needed,  a hair clipper should 
be used so as not to damage the skin tissue.  It is 
considered that scars made by the procedure of 
removing hair are vulnerable to surgical site infection.  
Compliance with all these fundamental principles can 
lead to more eﬀective infection prophylaxis.  On the 
other hand,  the selection of prophylactic antibiotic 
might be less important since S. lugdunensis is gener-
ally sensitive to various kinds of antibiotics.
　 In summary,  this is the ﬁrst well-documented case 
report of VGI caused by S. lugdunensis.  FP bypass 
operation can place patients at a relatively high risk 
for S. lugdunensis infection since the organism charac-
teristically resides at the inguinal area and the opera-
tion embeds prosthetic devices.  We need to pay more 
attention to the clinical characteristics of cardiovas-
cular infections caused by this potentially fatal organ-
ism,  S. lugdunensis.
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